054180 — Medicox Co Income Statement
0.000.00%
- KR₩36bn
- KR₩37bn
- KR₩27bn
Annual income statement for Medicox Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 June 30th | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 25,225 | 16,190 | 17,449 | 20,296 | 26,875 |
Cost of Revenue | |||||
Gross Profit | 4,037 | 2,151 | 505 | 569 | 1,921 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 26,224 | 22,114 | 34,455 | 43,288 | 36,561 |
Operating Profit | -999 | -5,924 | -17,006 | -22,992 | -9,686 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2,619 | -8,583 | -23,938 | -41,804 | -29,104 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2,640 | -8,583 | -23,938 | -41,804 | -29,104 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -2,228 | -8,583 | -23,935 | -42,619 | -32,378 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -2,228 | -8,583 | -23,935 | -42,619 | -32,378 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -341 | -923 | -1,230 | -1,436 | -1,038 |
Dividends per Share |